Sensus Healthcare, Inc. Increase (Decrease) in Other Current Assets
Sensus Healthcare, Inc. (SRTS) reported Increase (Decrease) in Other Current Assets of $62.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2026-08-14
- Sensus Healthcare, Inc. increase (decrease) in other current assets for the quarter ending 2026-06-30 was $38.00K, a 95.34% decline year-over-year.
- Sensus Healthcare, Inc. increase (decrease) in other current assets for the quarter ending 2026-03-31 was $24.00K, a 7.69% decline year-over-year.
- Sensus Healthcare, Inc. increase (decrease) in other current assets for the quarter ending 2025-12-31 was -$352.00K.
- Sensus Healthcare, Inc. increase (decrease) in other current assets for the quarter ending 2025-09-30 was -$314.00K, a 164.08% decline year-over-year.
- Sensus Healthcare, Inc. increase (decrease) in other current assets for fiscal 2025 was $176.00K, a 71.57% decline from fiscal 2024.
- Sensus Healthcare, Inc. increase (decrease) in other current assets for fiscal 2024 was $619.00K, a 171.49% increase from fiscal 2023.
- Sensus Healthcare, Inc. increase (decrease) in other current assets for fiscal 2023 was $228.00K.
- Sensus Healthcare, Inc. increase (decrease) in other current assets for fiscal 2022 was -$711.00K.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $38.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $62.00K 10-Q · filed 2026-08-14 | -$290.00K derived: sum of 3 quarters · filed 2026-08-14 | -$604.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $24.00K 10-Q · filed 2026-05-13 | -$328.00K derived: sum of 2 quarters · filed 2026-05-13 | -$642.00K derived: sum of 3 quarters · filed 2026-05-13 | $174.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$352.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$666.00K derived: sum of 2 quarters · filed 2026-03-04 | $150.00K derived: sum of 3 quarters · filed 2026-08-14 | $176.00K 10-K · filed 2026-03-04 |
| 2025-09-30 | -$314.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $502.00K derived: sum of 2 quarters · filed 2026-08-14 | $528.00K 10-Q · filed 2025-11-12 | $439.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $816.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $842.00K 10-Q · filed 2026-08-14 | $753.00K derived: sum of 3 quarters · filed 2026-08-14 | $1.24M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $26.00K 10-Q · filed 2026-05-13 | -$63.00K derived: sum of 2 quarters · filed 2026-05-13 | $427.00K derived: sum of 3 quarters · filed 2026-05-13 | $364.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$89.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $401.00K derived: sum of 2 quarters · filed 2026-03-04 | $338.00K derived: sum of 3 quarters · filed 2026-03-04 | $619.00K 10-K · filed 2026-03-04 |
| 2024-09-30 | $490.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $427.00K derived: sum of 2 quarters · filed 2025-11-12 | $708.00K 10-Q · filed 2025-11-12 | $256.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$63.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $218.00K 10-Q · filed 2025-08-12 | -$234.00K derived: sum of 3 quarters · filed 2025-08-12 | -$263.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $281.00K 10-Q · filed 2025-05-15 | -$171.00K derived: sum of 2 quarters · filed 2025-05-15 | -$200.00K derived: sum of 3 quarters · filed 2025-05-15 | $194.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$452.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | -$481.00K derived: sum of 2 quarters · filed 2025-03-05 | -$87.00K derived: sum of 3 quarters · filed 2025-03-05 | $228.00K 10-K · filed 2025-03-05 |
| 2023-09-30 | -$29.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $365.00K derived: sum of 2 quarters · filed 2024-11-14 | $680.00K 10-Q · filed 2024-11-14 | $356.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $394.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $709.00K 10-Q · filed 2024-08-13 | $385.00K derived: sum of 3 quarters · filed 2024-08-13 | |
| 2023-03-31 | $315.00K 10-Q · filed 2024-05-10 | -$9.00K derived: sum of 2 quarters · filed 2024-05-10 | ||
| 2022-12-31 | -$324.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$711.00K 10-K · filed 2024-03-15 | ||
| 2022-09-30 | -$387.00K 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B |